Hiroo Nakagawa

Basis for dosing time-dependent change in the anti-tumor effect of imatinib in mice.

H. Aramaki, S. Higuchi, S. Ohdo, 2006, Biochemical pharmacology.

Modulation of circadian rhythm of DNA synthesis in tumor cells by inhibiting platelet-derived growth factor signaling.

S. Ohdo, S. Koyanagi, Naoya Matsunaga, 2008, Journal of pharmacological sciences.

Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.

Satoru Koyanagi, Hiroshi Shimeno, Noboru Tanigawa, 2003, Biochemical pharmacology.

Optimizing the Dosing Schedule of TNP-470 [O-(Chloroacetyl-carbamoyl) Fumagillol] Enhances Its Antitumor and Antiangiogenic Efficacies

S. Ohdo, S. Koyanagi, S. Soeda, 2003, Journal of Pharmacology and Experimental Therapeutics.

A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells.

Satoru Koyanagi, Hiroshi Shimeno, H. Aramaki, 2003, Cancer research.

Daily expression of clock genes in whole blood cells in healthy subjects and a patient with circadian rhythm sleep disorder.

S. Higuchi, S. Ohdo, T. Jodoi, 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells

S. Ohdo, S. Koyanagi, Naoya Matsunaga, 2007, Pharmacogenetics and genomics.

24-Hour Oscillation of Mouse Methionine Aminopeptidase2, a Regulator of Tumor Progression, Is Regulated by Clock Gene Proteins

S. Higuchi, S. Ohdo, S. Koyanagi, 2004, Cancer Research.